Key points are not available for this paper at this time.
Twenty five patients with Raynaud's phenomenon due to systemic sclerosis were infused with prostacyclin (PGI2). In 88% of the patients there was objective improvement, monitored by thermography or radiometry.
Dowd et al. (1982) studied this question.